Skip to main content

Nurix Therapeutics Inc

For the period ended May 20, 2024. Filed Mar 27, 2024.

View on SEC.gov

About this filing

What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.

May 20, 2024 · Filed Mar 27, 2024

NRIX$15.30+3.1%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits
Contents

Pay versus Performance

In accordance with rules adopted by the SEC pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, we provide the following disclosure regarding executive compensation for our principal executive officer (“PEO”) and Non-PEO NEOs and Company performance for the fiscal years listed below. The Compensation Committee did not consider the pay versus performance disclosure below in making its pay decisions for any of the years shown.

Year​​Summary Compensation Table Total for PEO(1) ($)​​Compensation Actually Paid to PEO(1)(2)(3) ($)​​Average Summary Compensation Table Total for Non-PEO NEOs(1) ($)​​Average Compensation Actually Paid to Non-PEO NEOs(1)(2)(3) ($)​​Value of Initial Fixed $100 Investment based on:(4)TSR ($)​​Net Income ($ Millions)
2023​​4,363,120​​(913,889)​​1,622,372​​125,731​​21.58​​(143.9)
2022​​9,416,222​​(5,024,024)​​4,066,182​​916,179​​42.99​​(180.4)
(1)Arthur T. Sands was our PEO for each year presented. The individuals comprising the Non-PEO NEOs for each year presented are listed below.

2022-2023

Hans van Houte

Gwenn M. Hansen

(2)The amounts shown for Compensation Actually Paid have been calculated in accordance with Item 402(v) of Regulation S-K and do not reflect compensation actually earned, realized, or received by the Company’s NEOs. These amounts reflect the Summary Compensation Table Total with certain adjustments as described in footnote 3 below.
(3)Compensation Actually Paid reflects the exclusions and inclusions for the PEO and the Non-PEO NEOs as set forth below. Equity values are calculated in accordance with FASB ASC Topic 718. Amounts in the Exclusion of Stock Awards and Option Awards column are the amounts from the Stock Awards and Option Awards columns set forth in the Summary Compensation Table.
Year​​Summary Compensation Table Total for PEO ($)​​Exclusion of Stock Awards and Option Awards for PEO ($)​​Inclusion of Equity Values for PEO ($)​​Compensation Actually Paid to PEO ($)
2023​​4,363,120​​(3,376,799)​​(1,900,210)​​(913,889)
2022​​9,416,222​​(8,505,239)​​(5,935,007)​​(5,024,024)
Year​​Average Summary Compensation Table Total for Non-PEO NEOs ($)​​Average Exclusion of Stock Awards and Option Awards for Non-PEO NEOs ($)​​Average Inclusion of Equity Values for Non-PEO NEOs ($)​​Average Compensation Actually Paid to Non-PEO NEOs ($)
2023​​1,622,372​​(930,004)​​(566,638)​​125,731
2022​​4,066,182​​(3,410,167)​​260,164​​916,179

The amounts in the Inclusion of Equity Values in the tables above are derived from the amounts set forth in the following tables:

Year​​Year-End Fair Value of Equity Awards Granted During Year That Remained Unvested as of Last Day of Year for PEO ($)​​Change in Fair Value from Last Day of Prior Year to Last Day of Year of Unvested Equity Awards for PEO ($)​​Vesting-Date Fair Value of Equity Awards Granted During Year that Vested During Year for PEO ($)​​Change in Fair Value from Last Day of Prior Year to Vesting Date of Unvested Equity Awards that Vested During Year for PEO ($)​​Fair Value at Last Day of Prior Year of Equity Awards Forfeited During Year for PEO ($)​​Value of Dividends or Other Earnings Paid on Equity Awards Not Otherwise Included for PEO ($)​​Total - Inclusion of Equity Values for PEO ($)
2023​​1,272,157​​(2,666,999)​​633,090​​(1,138,458)​​—​​—​​(1,900,210)
2022​​4,613,780​​(6,190,508)​​672,511​​(5,030,790)​​—​​—​​(5,935,007)
Year​​Average Year-End Fair Value of Equity Awards Granted During Year That Remained Unvested as of Last Day of Year for Non-PEO NEOs ($)​​Average Change in Fair Value from Last Day of Prior Year to Last Day of Year of Unvested Equity Awards for Non-PEO NEOs ($)​​Average Vesting-Date Fair Value of Equity Awards Granted During Year that Vested During Year for Non-PEO NEOs ($)​​Average Change in Fair Value from Last Day of Prior Year to Vesting Date of Unvested Equity Awards that Vested During Year for Non-PEO NEOs ($)​​Average Fair Value at Last Day of Prior Year of Equity Awards Forfeited During Year for Non-PEO NEOs ($)​​Average Value of Dividends or Other Earnings Paid on Equity Awards Not Otherwise Included for Non-PEO NEOs ($)​​Total - Average Inclusion of Equity Values for Non-PEO NEOs ($)
2023​​376,844​​(807,861)​​155,628​​(291,249)​​—​​—​​(566,638)
2022​​1,771,807​​(1,125,605)​​341,153​​(727,192)​​—​​—​​260,164
(4)Assumes $100 was invested in the Company for the period starting November 30, 2021, through the end of the listed year. Historical stock performance is not necessarily indicative of future stock performance.

Relationship Between PEO and Non-PEO NEO Compensation Actually Paid and Company Total Shareholder Return (“TSR”)

The following chart sets forth the relationship between Compensation Actually Paid to our PEO, the average of Compensation Actually Paid to our Non-PEO NEOs, and the Company’s cumulative TSR over the two most recently completed fiscal years.

Relationship Between PEO and Non-PEO NEO Compensation Actually Paid and Net Income

The following chart sets forth the relationship between Compensation Actually Paid to our PEO, the average of Compensation Actually Paid to our Non-PEO NEOs, and our Net Income during the two most recently completed fiscal years.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.